Top Mesothelioma Researchers Say Survival May Not Depend On Surgery Type, According To Surviving Mesothelioma

Share Article

The latest, largest study on mesothelioma surgery finds little outcome difference between the top two techniques.

Little Difference Found Between Mesothelioma Surgery Survival

EPP vs P/D: No Survival DIfference

There were no differences between cohorts in 30-day readmission or mortality.

A newly-published report on the outcomes of more than 1,300 mesothelioma patients shows that survival may not depend on whether a patient has lung-sparing or lung-removing surgery. Surviving Mesothelioma has the details. Click here to read the full article.

The study utilized data from the National Cancer Database and included malignant mesothelioma patients who had either lung-removing extrapleural pneumonectomy surgery or lung-sparing pleurectomy/decortication.

“Median overall survival in the EPP and P/D groups was 19 versus 16 months; no differences were observed after propensity-matching,” reports author and radiation oncologist Vivek Verma, MD, of the University of Nebraska Medical Center in Omaha. “There were no differences between cohorts in 30-day readmission or mortality.”

The report in the Journal of Thoracic Oncology also revealed that P/D was nearly four times as common as EPP and that people who underwent EPP tended to be younger, live in more rural areas, and be treated at academic centers.

“This study suggests that mesothelioma surgery decisions may have a lot to do with where a person lives and what kind of a surgeon he or she has access to, rather than just the patient’s clinical considerations,” says Alex Strauss, Managing Editor for Surviving Mesothelioma.

To read more about the new surgery study findings, see New Research Finds Little Survival Difference Between Mesothelioma Surgeries, now available on the Surviving Mesothelioma website.

Verma, V, et al, “National Cancer Data Base Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma”, August 23, 2017, Journal of Thoracic Oncology, Epub ahead of print, http://www.jto.org/article/S1556-0864(17)30687-1/fulltext

For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website